Conference abstract · 20 Mar 2017
Conference abstractPublished 11 Dec 2018
Mesenchymal stem cell expansion with small molecules
Yeditepe University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The development of commercially available stem cell sources has let the researchers to modulate the immune system and provide valuable assets for regenerative medicine and cell-based tissue repairing systems. Mesenchymal stem cells are great candidate for transplantation based therapies with their immunomodulatory abilities, differentiation potentials because of their easy accessibility. They are present in the adult body, they can self-renew themselves and exhibit multipotency. They can differentiate to bone, fat, chondrocyte and other various cell types under specific conditions including neuronal cells. They can be obtained from different tissue types including; bone marrow, adipose tissue, umbilical cord, dental tissue, etc. Isolation of MSC is easy but there are major challenges on mobilization, expansion and understanding the differentiation mechanism. If these challenges overcame, MSCs show great potential for experimental and clinical applications. Stem cell based therapeutic approaches have also shown to be affective in neurodegenerative diseases’ treatment. In our study we focused on expansion of mouse bone marrow MSCs, with small molecule treatment, with that we hope to achieve increased mobilization results as well. We selected four effective molecules firstly by WST-1 assay, cell viability assay was supported by pyronin y/hoechst staining. To see the effects on cell mechanism; cell cycle analysis, apoptosis analysis were conducted. The results did not suggest any misconduct on our MSC culture. Next, we performed RT-PCR and checked if there were any negative changes on HDRrelated, CDKI, S-Phase and MSC immunomodulatory gene expressions. Also with CFU assay, we showed that after small molecule treatment, differentiation ability of our MSC was not lost. Our first and most effective molecule is a GSK-3 inhibitor that stabilizes free cytosolic β-catenin and inhibits differentiation. Second one is a p38-MAPK inhibitor. In conclusion, we found a safe and reliable way of in vitro expansion of mouse BM-MSCs. Our next step is in vivo trials by small molecule treated stem cell transplanation to SCID mice. With all this, our goal is to carry this knowledge to therapeutic field.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Nov 2018
Mesenchymal stem cell expansion with small molecules
Conference abstract · 18 Mar 2020
Mesenchymal Stem Cell Expansion with Small Molecules
Conference abstract · 2019
EFFECT OF STEMREGENIN1 AND SB431542 SMALL MOLECULES ON EX VIVO EXPANSION OF UMBILICAL CORD BLOOD HEMATOPOIETIC STEM CELLS ON BIOCOMPATIBLE POLYETHER SULFONE NANOFIBER SCAFFOLDS
Conference abstract · 2020
A Small Molecule-Based Culture System to Prevent Replicative Senescence and Promote Osteogenic properties of Mesenchymal Stem Cells
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Lamia Yazgi Alyazici”
